Edwards Lifesciences Corporation
EW | NYSE
$94.25
+$2.24 (+2.43%)
Nov 2, 2026, 10:31 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 2.94B | 3.05B | 1.13B | 769M | 862.8M | 1.18B |
Short-Term Investments | 1.29B | 930.7M | 500.5M | 446.3M | 604M | 219.4M |
Long-Term Investments | 773.9M | 307.9M | 583.9M | 1.24B | 1.83B | 801.6M |
Other Long-Term Assets | 234.9M | 732.4M | 774.3M | 299.1M | 110.8M | 119.6M |
Receivables | 912.1M | 727.4M | 828.1M | 699.1M | 664.9M | 602.8M |
Inventory | 1.13B | 1.09B | 903.5M | 875.5M | 726.7M | 802.3M |
Other Current Assets | 338.8M | 374.4M | 542.5M | 195.9M | 237.1M | 208.2M |
Total Current Assets | 6.74B | 6.29B | 4.04B | 3.1B | 3.18B | 3.09B |
Property-Plant & Equipment | 1.91B | 1.78B | 1.68B | 1.73B | 1.64B | 1.49B |
Goodwill & Intangibles | 2.9B | 2.95B | 1.54B | 1.45B | 1.49B | 1.5B |
Total Long-Term Assets | 6.96B | 6.77B | 5.33B | 5.2B | 5.32B | 4.15B |
Total Assets | 13.7B | 13.06B | 9.36B | 8.29B | 8.5B | 7.24B |
Account Payables | 227.5M | 197.4M | 186.6M | 201.9M | 204.5M | 196.5M |
Deferred Revenue | 27.2M | 53.7M | n/a | n/a | n/a | n/a |
Short-Term Debt | 24.5M | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 874.5M | 442.7M | 530.2M | 305M | 342.7M | 290.5M |
Total Current Liabilities | 1.81B | 1.51B | 1.2B | 1.02B | 1.03B | 893.9M |
Long-Term Debt | 598.3M | 597.7M | 597M | 596.3M | 595.7M | 595M |
Other Long-Term Liabilities | 865M | 810.6M | 786.2M | 797.6M | 969.6M | 1.1B |
Total Long-Term Liabilities | 1.55B | 1.49B | 1.45B | 1.46B | 1.63B | 1.77B |
Total Liabilities | 3.36B | 2.99B | 2.64B | 2.49B | 2.67B | 2.66B |
Total Debt | 705.4M | 700M | 685.1M | 691.3M | 690.3M | 694.9M |
Book Value | 10.34B | 10.06B | 6.72B | 5.81B | 5.84B | 4.57B |
Book Value Per Share | 17.65 | 16.79 | 11.03 | 9.30 | 9.25 | 7.24 |
Common Stock | 658.7M | 654.8M | 650.5M | 646.3M | 642M | 636.4M |
Retained Earnings | 14.24B | 13.17B | 8.99B | 7.59B | 6.07B | 4.57B |
Comprehensive Income | -238.3M | -244.5M | -242.8M | -254.9M | -157.7M | -161.1M |
Shareholders Equity | 10.34B | 10B | 6.65B | 5.81B | 5.84B | 4.57B |
Total Investments | 2.06B | 1.24B | 1.08B | 1.69B | 2.44B | 1.02B |
Add to Watchlist
Select watchlists to add or remove EW